Axonics Inc


Market Cap$3.45B

Compare Axonics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Axonics IncAxonics Inc-287.70%-2%11.4-
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9

Current Fair Value

8.4% upside

Undervalued by 8.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.45 Billion
Enterprise Value$3.11 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.24
Outstanding Shares50,662,028
Avg 30 Day Volume873,884


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-287.71
Price to Sales11.44
Price to Book Ratio5.72
Enterprise Value to Revenue9.08
Enterprise Value to EBIT-287.86
Enterprise Value to Net Income-260
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About Axonics ModulationTechnologies Inc

CEO: Raymond Cohen